◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › AAQ1

aap Implantate AG (AAQ1) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-29

aap Implantate AG (AAQ1) operates in the Medical Devices industry and is headquartered in Berlin, Germany with about 99 employees. Its market capitalization is roughly €22 million. In the fiscal year ended 2025-12-31, AAQ1 reported €12M in revenue and (€3M) in net income.

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials.

Interactive charts & full statements →

AAQ1 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€12M€12M€12M€12M
Gross Profit€11M€11M€10M€11M
Operating Income (EBIT)(€2M)(€3M)(€7M)(€3M)
Net Income(€3M)(€4M)(€8M)(€3M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AAQ1 Free Cash Flow History

AAQ1 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€14M€16M€17M€20M
Total Liabilities€5M€5M€9M€7M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AAQ1 viewer.

Other Companies in Medical Devices

← AAPYAll “A” companiesAARD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.